Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019152
Filing Date
2025-07-02
Accepted
2025-07-02 18:51:03
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 form4-07022025_100759.html 4  
1 form4-07022025_100759.xml 4 6227
  Complete submission text file 0001415889-25-019152.txt   7694
Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address
BEHRENS M KATHLEEN (Reporting) CIK: 0001211701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 251103134

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)